INS and metabolic dysfunction-associated steatotic liver disease: In a small study involving 39 patients with biopsy-proven NAFLD who were followed for a median period of 2.4 years, Hamaguchi et al. showed that insulin use and lower HbA1c levels were associated with a significant improvement in liver fibrosis, independent of age, sex and BMI [20].